Posted on 26 November 2012
On November 19, 2012, VIVUS, Inc., initiated the Qsymia Get Started! Free Trial Offer Program. The Company is offering eligible patients a Free Trial Offer on a valid prescription for up to a 14 capsule quantity of the Qsymia Starting Dose, 3.75 mg/23 mg (phentermine and topiramate extended-release). Eligible patients are able to receive up [...] Continue Reading...
Posted on 18 September 2012
Qsymia (pronounced kyoo-SIM-ee-uh), the new diet pill which was finally approved by the U.S. Food and Drug Administration this July is now available for prescription to obese or at-risk overweight patients. The oral medication can only be obtained by patients with their doctor’s prescription and comes with a number of special conditions. view full post [...] Continue Reading...
Posted on 08 September 2012
Finding a local Doctor to evaluate your weight and health is the best way to get a prescription for Qsymia. A weight loss doctor in your area should be easy to find using your local yellow pages or you can search online for trusted doctors based on reviews from friends or family and internet review [...] Continue Reading...
Vivus (NASDAQ:VVUS) released Monday morning that Qsymia is now commercially available as an aid for weight loss. VVUS had guided for a 4Q 2012 launch of the drug, so the news comes a bit earlier than expected. …
Vivus' Qsymia still faces questions about pricing compared to generics. Click to view a price quote on VVUS . Click to research the Drugs industry.
WASHINGTON (AP) — Las autoridades sanitarias de Estados Unidos aprobaron el martes un fármaco para pérdida de peso que muchos médicos consideran la terapia más efectiva entre una nueva generación de pà ldoras contra la obesidad.
Shares of weight loss drugmaker Vivus Inc. rose Monday after the company announced its highly anticipated pill Qsymia is now available in the U.S.THE SPARK: The company said in a regulatory filing that …
WASHINGTON (AP) — Las autoridades sanitarias de Estados Unidos aprobaron el martes un fármaco para pérdida de peso que muchos médicos consideran la terapia más efectiva entre una nueva generación de píldoras contra la obesidad.
WASHINGTON (AP) — Las autoridades sanitarias de Estados Unidos aprobaron el martes un fármaco para pérdida de peso que muchos médicos consideran la terapia más efectiva entre una nueva generación de píldoras contra la obesidad.
These three factors could hold the key to big gains with Arena Pharmaceuticals.
The hCG diet from Diet Doc Weight Loss results of an in-house study show that the Diet Doc hCG Diet helped people lose weight fast with patients reporting an average of 30 pounds per month as compared to 10% body mass weight loss in one year or for a 200 pound person, 20 pounds in 12 months on the new FDA approved diet pill Qsymia also known as Belviq.Los Angeles, CA (PRWEB) September 06, 2012 …
Obesity Pandemic Addressed By Collaboration Between American, Swiss, Japanese Companies
MOUNTAIN VIEW, Calif. — VIVUS, Inc. today announced that Timothy Morris, Chief Financial Officer, and Barbara Troupin, Vice President of Scientific Communication and Risk Management, will present an overview …
Copyright © Qsymia Diet Pills Support Group. NewsPress Theme by 
